Literature DB >> 16540517

Radiation-induced delayed cell death in a hypomorphic Artemis cell line.

Paul M Evans1, Lisa Woodbine, Enriquetta Riballo, Andrew R Gennery, Michael Hubank, Penny A Jeggo.   

Abstract

Null mutations in Artemis confer a condition described as RS-SCID, in which patients display radiosensitivity combined with severe combined immunodeficiency. Here, we characterize the defect in Artemis in a patient who displayed progressive combined immunodeficiency (CID) and elevated lymphocyte apoptosis. The patient is a compound heterozygote with novel mutations in both alleles, resulting in Artemis proteins with either L70 deletion or G126D substitution. Both mutational changes impact upon Artemis function and a fibroblast cell line derived from the patient (F96-224) has greatly reduced Artemis protein. In contrast to Artemis null cell lines, which fail to repair a subset of DNA double strand breaks (DSBs) induced by ionizing radiation, F96-224 cells show slow but residual DSB rejoining. Despite showing intermediate cellular and clinical features, F96-224 cells are as radiosensitive as Artemis null cell lines. We developed a FACS-based assay to examine cell division and cellular characteristics for 10 days following exposure to ionizing radiation (2 and 4 Gy). This analysis demonstrated that F96-224 cells show delayed cell death when compared with rapid growth arrest of an Artemis null cell line, and the emergence of a cycling population shown by a control line. F96-224 cells also display elevated chromosome aberrations when compared with control cells. F96-224 therefore represents a novel phenotype for a hypomorphic cell line. We suggest that delayed cell death contributes to the progressive CID phenotype of the Artemis patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540517     DOI: 10.1093/hmg/ddl050

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?

Authors:  Morton J Cowan; Andrew R Gennery
Journal:  J Allergy Clin Immunol       Date:  2015-06-06       Impact factor: 10.793

2.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

3.  Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.

Authors:  Kerstin Felgentreff; Yu Nee Lee; Francesco Frugoni; Likun Du; Mirjam van der Burg; Silvia Giliani; Ilhan Tezcan; Ismail Reisli; Ester Mejstrikova; Jean-Pierre de Villartay; Barry P Sleckman; John Manis; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2015-04-25       Impact factor: 10.793

Review 4.  Role of non-homologous end joining in V(D)J recombination.

Authors:  Shruti Malu; Vidyasagar Malshetty; Dailia Francis; Patricia Cortes
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs.

Authors:  Shruti Malu; Pablo De Ioannes; Mikhail Kozlov; Marsha Greene; Dailia Francis; Mary Hanna; Jesse Pena; Carlos R Escalante; Aya Kurosawa; Hediye Erdjument-Bromage; Paul Tempst; Noritaka Adachi; Paolo Vezzoni; Anna Villa; Aneel K Aggarwal; Patricia Cortes
Journal:  J Exp Med       Date:  2012-04-23       Impact factor: 14.307

6.  The spatial organization of non-homologous end joining: from bridging to end joining.

Authors:  Takashi Ochi; Qian Wu; Tom L Blundell
Journal:  DNA Repair (Amst)       Date:  2014-03-11

Review 7.  DNA ligase IV syndrome; a review.

Authors:  Thomas Altmann; Andrew R Gennery
Journal:  Orphanet J Rare Dis       Date:  2016-10-07       Impact factor: 4.123

8.  Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells.

Authors:  Kerstin Felgentreff; Likun Du; Katja G Weinacht; Kerry Dobbs; Margarita Bartish; Silvia Giliani; Thorsten Schlaeger; Alexander DeVine; Axel Schambach; Lisa J Woodbine; Graham Davies; Sachin N Baxi; Mirjam van der Burg; Jack Bleesing; Andrew Gennery; John Manis; Qiang Pan-Hammarström; Luigi D Notarangelo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

9.  Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination.

Authors:  Likun Du; Mirjam van der Burg; Sergey W Popov; Ashwin Kotnis; Jacques J M van Dongen; Andrew R Gennery; Qiang Pan-Hammarström
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

10.  Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair.

Authors:  Julio C Morales; Patricia Richard; Amy Rommel; Farjana J Fattah; Edward A Motea; Praveen L Patidar; Ling Xiao; Konstantin Leskov; Shwu-Yuan Wu; Walter N Hittelman; Cheng-Ming Chiang; James L Manley; David A Boothman
Journal:  Nucleic Acids Res       Date:  2014-03-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.